Ursodeoxycholic acid (Santen Pharmaceutical)

N/A

Report date: 2025/09/03 17:52:53

Base Information

Drug NameUrsodeoxycholic acid (Santen Pharmaceutical)
Drug Alias NameSTN1013600
ClassificationSmall molecules > Steroids
Mechanisms of ActionBile acid receptor FXR antagonistsApoptosis inhibitorsCholesterol inhibitors
TargetsBile acid receptor FXRCholesterol
Therapy Area/IndicationsPresbyopia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanten Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPresbyopia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A